Stock Scorecard
Stock Summary for Transmedics Group Inc (TMDX) - $134.56 as of 2/27/2026 7:07:03 PM EST
Total Score
9 out of 30
Safety Score
45 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for TMDX
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for TMDX
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for TMDX
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for TMDX
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for TMDX (45 out of 100)
| Stock Price Rating (Max of 10) | 10 |
| Historical Stock Price Rating (Max of 10) | 9 |
| Stock Price Trend (Max of 10) | 10 |
| Book Value (Max of 10) | 5 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 4 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 4 |
| Trading Volume (Max of 10) | 8 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | -10 |
Latest News for for TMDX
Financial Details for TMDX
Company Overview |
|
|---|---|
| Ticker | TMDX |
| Company Name | Transmedics Group Inc |
| Country | N/A |
| Description | TransMedics Group, Inc., a commercial-stage medical technology company, is dedicated to transforming organ transplant therapy for patients with end-stage organ failure in the United States and internationally. The company is headquartered in Andover, Massachusetts. |
| Sector Name | HEALTHCARE |
| Industry Name | MEDICAL DEVICES |
| Most Recent Quarter | 9/30/2025 |
| Next Earnings Date | 5/5/2026 |
Stock Price History |
|
| Last Day Price | 134.56 |
| Price 4 Years Ago | 61.72 |
| Last Day Price Updated | 2/27/2026 7:07:03 PM EST |
| Last Day Volume | 825,089 |
| Average Daily Volume | 799,786 |
| 52-Week High | 156.00 |
| 52-Week Low | 62.07 |
| Last Price to 52 Week Low | 116.79% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 45.58 |
| Sector PE | 46.86 |
| 5-Year Average PE | -9.97 |
| Free Cash Flow Ratio | 9.42 |
| Industry Free Cash Flow Ratio | 26.39 |
| Sector Free Cash Flow Ratio | 25.71 |
| Current Ratio Most Recent Quarter | 7.14 |
| Total Cash Per Share | 14.29 |
| Book Value Per Share Most Recent Quarter | 10.40 |
| Price to Book Ratio | 12.44 |
| Industry Price to Book Ratio | 4.96 |
| Sector Price to Book Ratio | 52.77 |
| Price to Sales Ratio Twelve Trailing Months | 8.12 |
| Industry Price to Sales Ratio Twelve Trailing Months | 4.39 |
| Sector Price to Sales Ratio Twelve Trailing Months | 22.39 |
| Analyst Buy Ratings | 7 |
| Analyst Strong Buy Ratings | 2 |
Share Statistics |
|
| Total Shares Outstanding | 34,174,300 |
| Market Capitalization | 4,598,493,808 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 450.10% |
| Annual Earnings Growth | 436.58% |
| Reported EPS 12 Trailing Months | 2.54 |
| Reported EPS Past Year | 2.33 |
| Reported EPS Prior Year | 1.01 |
| Net Income Twelve Trailing Months | 190,291,000 |
| Net Income Past Year | 190,291,000 |
| Net Income Prior Year | 35,464,000 |
| Quarterly Revenue Growth YOY | 32.20% |
| 5-Year Revenue Growth | 88.21% |
| Operating Margin Twelve Trailing Months | 16.20% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 488,366,000 |
| Total Cash Past Year | 488,366,000 |
| Total Cash Prior Year | 336,650,000 |
| Net Cash Position Most Recent Quarter | -18,319,000 |
| Net Cash Position Past Year | -20,945,000 |
| Long Term Debt Past Year | 509,311,000 |
| Long Term Debt Prior Year | 509,311,000 |
| Total Debt Most Recent Quarter | 506,685,000 |
| Equity to Debt Ratio Past Year | 0.48 |
| Equity to Debt Ratio Most Recent Quarter | 0.48 |
| Total Stockholder Equity Past Year | 473,100,000 |
| Total Stockholder Equity Prior Year | 228,603,000 |
| Total Stockholder Equity Most Recent Quarter | 473,100,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 133,589,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 3.91 |
| Free Cash Flow Past Year | 133,589,000 |
| Free Cash Flow Prior Year | -80,941,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -0.19 |
| MACD Signal | -0.17 |
| 20-Day Bollinger Lower Band | 114.88 |
| 20-Day Bollinger Middle Band | 130.62 |
| 20-Day Bollinger Upper Band | 146.36 |
| Beta | 1.98 |
| RSI | 47.69 |
| 50-Day SMA | 0.00 |
| 150-Day SMA | 0.00 |
| 200-Day SMA | 0.00 |
System |
|
| Modified | 2/26/2026 9:55:08 AM EST |